Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.
about
Cardiomyopathy in Friedreich ataxia: clinical findings and researchCardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.Untangling autophagy measurements: all fluxed up.The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and deathInvestigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.Cardiac involvement in hereditary ataxiasChildhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and OutcomesManagement and therapy for cardiomyopathy in Friedreich's ataxia.Cardiomyopathy of Friedreich ataxia.Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.The role of stress cardiac magnetic resonance in women.Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction.Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle.Identification of cardioprotective drugs by medium-scale pharmacological screening on a cardiac model of Friedreich's ataxiaNeuromuscular diseases with hypertrophic cardiomyopathy
P2860
Q26827933-98326D34-2C67-4A48-BE39-69C300979091Q34989407-214C50F8-81B5-482A-B0DA-A985821B3960Q35036484-85F042ED-01BE-43BD-89D7-784E618FE8AEQ35052617-3DAACB1B-A7EF-4632-B796-B80F2F0C42FAQ35814768-FE630FA4-BC9C-4475-ADCB-77B86BE06DBFQ35899984-F115963B-B191-4AFE-8226-A8A38A34BBD7Q35999436-286B7A7D-CAF4-4BA3-B6F0-8BB954E75395Q36908105-BB668F49-45BE-4337-8CB8-D7DC9E562F37Q36964084-DEB72FD5-FB45-455A-A87F-E8F3549AEFB3Q37164152-ECD32111-0133-41C4-B805-10ED28DB6557Q38034809-94051C09-92FF-493E-B53C-D520910CACB0Q38121946-3C36B9B2-817D-41C4-BDCA-13027A766CDEQ38435433-86F34B66-A7FA-42FA-9CE5-406EB7C4F000Q39560578-925A8FEF-98E8-4846-93D1-81D3A1CB456EQ43842780-C98CBF7B-3B58-4505-8200-A4294A74878DQ47072694-3A914FE7-A6D4-4F0A-B491-E3107B73A142Q49979941-8F5D7E0C-3871-430D-B37B-5344BFA5E62BQ51841258-1A2F6D5C-49DD-4F57-8318-663C9B3FEEC5Q57175221-F7C10B2C-DB2C-4C12-A6FF-F7237D084AABQ58565564-1CCDF10B-5E59-4B38-AFEF-B78C2F019A43
P2860
Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@ast
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@en
type
label
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@ast
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@en
prefLabel
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@ast
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@en
P2093
P2860
P356
P1476
Impaired myocardial perfusion ...... pathy with metabolic syndrome.
@en
P2093
Anthony Lutton
Beth McCarthy
Chelsea Rankin
J Chad Hoyle
John T Kissel
John W Olesik
Kavita Phatak
Michael L Pennell
Roula Al-Dahhak
Subha V Raman
P2860
P304
P356
10.1093/EURHEARTJ/EHQ443
P577
2010-12-14T00:00:00Z